Log in | Register

Focus on fluid therapy and nutritional support

Yaseen M. Arabi| Anders Perner
Editorial
Volume 44, Issue 12 / December , 2018

Pages 2271 - 2273

No abstract available.

References

  1. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377. https://doi.org/10.1007/s00134-017-4683-6
  2. Machado FR, Levy MM, Rhodes A (2017) Fixed minimum volume resuscitation: pro. Intensive Care Med 43(11):1678–1680. https://doi.org/10.1007/s00134-016-4590-2
  3. Perner A, Singer M (2017) Fixed minimum fluid volume for resuscitation: con. Intensive Care Med 43(11):1681–1682. https://doi.org/10.1007/s00134-016-4581-3
  4. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM, FEAST Trial Group (2011) Mortality after fluid bolus in African children with severe infection. N Engl J Med 364(26):2483–2495. https://doi.org/10.1056/NEJMoa1101549
    • View reference on publisher's website
  5. Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, Beale R, Hartog CS, European Society of Intensive Care Medicine (2012) Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 38(3):368–383. https://doi.org/10.1007/s00134-012-2472-9
  6. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA, CHEST Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367(20):1901–1911. https://doi.org/10.1056/NEJMoa1209759
    • View reference on publisher's website
  7. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Moller MH, Elkjaer JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Soe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjaeldgaard AL, Fabritius ML, Mondrup F, Pott FC, Moller TP, Winkel P, Wetterslev J, 6S Trial Group, Scandinavian Critical Care Trials Group (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367(2):124–134. https://doi.org/10.1056/NEJMoa1204242
    • View reference on publisher's website
  8. European Medicines Agency (2018) Hydroxyethyl starch solutions for infusion. http://www.emaeuropaeu/ema/indexjsp?curl=pages/medicines/human/referrals/Hydroxyethyl_starch-containing_solutions/human_referral_prac_000012jsp&mid = WC0b01ac05805c516f. Accessed 24 Sept 2018
  9. Frank G (2018) HES: time to change my mind? Intensive Care Med 44(9):1577–1578. https://doi.org/10.1007/s00134-018-5124-x
  10. Wiedermann CJ, Bellomo R, Perner A (2017) Is the literature inconclusive about the harm from HES? No. Intensive Care Med 43(10):1523–1525. https://doi.org/10.1007/s00134-016-4275-x
  11. Ertmer C, Annane D, Van Der Linden P (2017) Is the literature inconclusive about the harm from HES? Yes. Intensive Care Med 43(10):1520–1522. https://doi.org/10.1007/s00134-016-4278-7
  12. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declere AD, Preiser JC, Outin H, Troche G, Charpentier C, Trouillet JL, Kimmoun A, Forceville X, Darmon M, Lesur O, Reignier J, Abroug F, Berger P, Clec’h C, Cousson J, Thibault L, Chevret S, CRISTAL Investigators (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310(17):1809–1817. https://doi.org/10.1001/jama.2013.280502
    • View reference on publisher's website
  13. Perner A, Haase N, Wetterslev J (2014) Mortality in patients with hypovolemic shock treated with colloids or crystalloids. JAMA 311(10):1067. https://doi.org/10.1001/jama.2014.830
    • View reference on publisher's website
  14. Schetz M, Shaw AD, Vincent JL (2017) Is the literature inconclusive about the harm of HES? We are not sure. Intensive Care Med 43(10):1526–1528. https://doi.org/10.1007/s00134-016-4329-0
  15. Doshi P (2018) EMA recommendation on hydroxyethyl starch solutions obscured controversy. BMJ 360:k1287. https://doi.org/10.1136/bmj.k1287
    • View reference on publisher's website
  16. Reintam Blaser A, Starkopf J, Alhazzani W, Berger MM, Casaer MP, Deane AM, Fruhwald S, Hiesmayr M, Ichai C, Jakob SM, Loudet CI, Malbrain ML, Montejo Gonzalez JC, Paugam-Burtz C, Poeze M, Preiser JC, Singer P, van Zanten AR, De Waele J, Wendon J, Wernerman J, Whitehouse T, Wilmer A, Oudemans-van Straaten HM, Working Group on Gastrointestinal Function (2017) Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med 43(3):380–398. https://doi.org/10.1007/s00134-016-4665-0
  17. Arabi YM, Casaer MP, Chapman M, Heyland DK, Ichai C, Marik PE, Martindale RG, McClave SA, Preiser JC, Reignier J, Rice TW, Van den Berghe G, van Zanten AR, Weijs PJ (2017) The intensive care medicine research agenda in nutrition and metabolism. Intensive Care Med. https://doi.org/10.1007/s00134-017-4711-6
  18. Marker S, Krag M, Moller MH (2017) What’s new with stress ulcer prophylaxis in the ICU? Intensive Care Med 43(8):1132–1134. https://doi.org/10.1007/s00134-017-4733-0
  19. Krag M, Marker S, Perner A, Wetterslev J, Wise MP, Schefold JC, Keus F, Guttormsen AB, Bendel S, Borthwick M, Lange T, Rasmussen BS, Siegemund M, Bundgaard H, Elkmann T, Jensen JV, Nielsen RD, Liboriussen L, Bestle MH, Elkjaer JM, Palmqvist DF, Backlund M, Laake JH, Badstolokken PM, Gronlund J, Breum O, Walli A, Winding R, Iversen S, Jarnvig IL, White JO, Brand B, Madsen MB, Quist L, Thornberg KJ, Moller A, Wiis J, Granholm A, Anthon CT, Meyhoff TS, Hjortrup PB, Aagaard SR, Andreasen JB, Sorensen CA, Haure P, Hauge J, Hollinger A, Scheuzger J, Tuchscherer D, Vuilliomenet T, Takala J, Jakob SM, Vang ML, Paelestik KB, Andersen KLD, van der Horst ICC, Dieperink W, Fjolner J, Kjer CKW, Solling C, Solling CG, Karttunen J, Morgan MPG, Sjobo B, Engstrom J, Agerholm-Larsen B, Moller MH, group S-It (2018) Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU. N Engl J Med. https://doi.org/10.1056/NEJMoa1714919
  20. Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S, Pelosi P, Keus F, Guttormsen AB, Schefold JC, Moller MH, SUP-ICU Investigators (2016) Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial. Trials 17(1):205. https://doi.org/10.1186/s13063-016-1331-3
    • View reference on publisher's website
  21. Alhazzani W, Guyatt G, Alshahrani M, Deane AM, Marshall JC, Hall R, Muscedere J, English SW, Lauzier F, Thabane L, Arabi YM, Karachi T, Rochwerg B, Finfer S, Daneman N, Alshamsi F, Zytaruk N, Heel-Ansdell D, Cook D, Canadian Critical Care Trials Group (2017) Withholding pantoprazole for stress ulcer prophylaxis in critically ill patients: a pilot randomized clinical trial and meta-analysis. Crit Care Med 45(7):1121–1129. https://doi.org/10.1097/CCM.0000000000002461
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement